Blar i Publikasjoner fra Cristin på forfatter "Tanum, Lars Håkon Reiestad"
-
Adverse childhood experiences and their association with substance use disorders in adulthood: A general population study (Young-HUNT)
Broekhof, Rosalie; Nordahl, Hans Morten; Tanum, Lars Håkon Reiestad; Selvik, Sara Germans (Peer reviewed; Journal article, 2023)Aim: To investigate the association of adverse childhood experiences (ACEs) and substance use disorders (alcohol and illicit drug use disorders), specifically by gender, in a large longitudinal non-clinical population ... -
Chronic Pain Among Patients With an Opioid Use Disorder
Latif, Zill-E-Huma; Skjærvø, Ingeborg; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad (American Journal on Addictions;, Peer reviewed; Journal article, 2021-03-19)Background and objectives: Chronic pain is not well understood in opioid-dependent populations. We report the prevalence of chronic pain and pain characteristics in an opioid-dependent population by treatment type and ... -
Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
Weimand, Bente; Solli, Kristin Klemmetsby; Wenche Helleren, Reichelt; Tanum, Lars Håkon Reiestad (Peer reviewed; Journal article, 2021)Opioid-dependence is a comprehensive, relapsing disorder with negative individual, - family, - and societal consequences. Recovery is difficult to achieve. Research has shown reduced substance use and improved healthand ... -
Levels of impulsivity, hyperactivity, and inattention and the association with mental health and substance use severity in opioid-dependent patients seeking treatment with extended-release naltrexone
Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas; Weimand, Bente; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad (Journal of Clinical Medicine;Volume 10 / Issue 19, Peer reviewed; Journal article, 2021-09-30)The level of impulsivity, hyperactivity, and inattention (IHI) is higher among patients with substance use disorder (SUD) than in the general population. However, the prevalence of such symptoms in patients seeking treatment ... -
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up
Gaulen, Zhanna; Saltyte Benth, Jurate; Fadnes, Lars T.; Brenna, Ida Halvorsen; Tanum, Lars Håkon Reiestad (Journal of Substance Abuse Treatment;Volume 135, April 2022, 108656, Peer reviewed; Journal article, 2021-02-15)Introduction: Life satisfaction (LS) in opioid-dependent individuals is lower than in the general population. This study aimed to explore changes in LS during short- and long-term treatment with extended-release naltrexone ... -
Not at all what I had expected: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study
Brenna, Ida Halvorsen; Marciuch, Anne; Birkeland, Bente; Veseth, Marius; Røstad, Bente; Løberg, Else-Marie; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Weimand, Bente (Peer reviewed; Journal article, 2021)Background: Extended-release naltrexone (XR-NTX), an opioid antagonist, has demonstrated equal treatment outcomes, in terms of safety, opioid use, and retention, to the recommended OMT medication buprenorphine. However, ... -
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial
Midgard, Håvard; Malme, Kristian Braathen; Pihl, Charlotte Meinich; Berg-Pedersen, Riikka Mari; Tanum, Lars Håkon Reiestad; Klundby, Ingvild; Haug, Anne; Tveter, Ida Giæver; Bjørnestad, Ronny; Olsen, Inge Christoffer; Finbråten, Ane-Kristine; Dalgard, Olav (Journal article; Peer reviewed, 2023)Background. We aimed to evaluate the efficacy of opportunistic treatment of hepatitis C virus (HCV) infection among hospitalized people who inject drugs (PWID). Methods. We performed a pragmatic, stepped wedge cluster ... -
Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
Marciuch, Anne; Birkeland, Bente; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Mathisen, Ida; Weimand, Bente (Peer reviewed; Journal article, 2023)Background and aims Recovery from substance use disorders (SUD) has traditionally been equated with abstinence. “Personal recovery” however emphasizes recovery as a unique and personal process, supported by changes in ... -
Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
Opheim, Arild; Gaulen, Zhanna; Solli, Kristin Klemmetsby; Latif, Zill-E-Huma; Fadnes, Lars T.; Saltyte Benth, Jurate; Kunøe, Nikolaj; Tanum, Lars Håkon Reiestad (American Journal on Addictions;Volume 30, Issue 5, September 2021, Peer reviewed; Journal article, 2021-09-06)Background and Objectives: Compare the risk of relapse to heroin and other illicit opioids among opioid‐dependent patients receiving treatment with extended‐release naltrexone (XR‐NTX) or buprenorphine‐naloxone (BP‐NLX). ... -
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial
Opheim, Arild; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Kloster, Pia Synnøve; Fadnes, Lars T.; Kunøe, Nikolaj; Gaulen, Zhanna; Tanum, Lars Håkon Reiestad (Peer reviewed; Journal article, 2023)ackground and objective: First study to assess any compensatory increase in use of non-opioid illicit substances and alcohol in opioid dependent patients randomized to treatment with extended-release naltrexone (XR-NTX) ...